Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EMBARC: Biomarkers of Antidepressant Response
NCT01407094Phase 2Completed
- Sponsor
- UT Southwestern Medical Center
- Start
- Jul 2011
- Primary completion
- Apr 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of sertraline in major depressive disorder (MDD), sponsored by UT Southwestern Medical Center. Started Jul 2011; status: completed.
02
Drugs
sertraline
03
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT01407094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01407094.